E-LIB Suche - Ergebnisse für: Chapman, M. John

1

Pitavastatin treatment remodels the HDL subclass lipidome a..:

Chapman, M. John ; Orsoni, Alexina ; Mellett, Natalie A....
Journal of Lipid Research. 65 (2024) 2 - p. 100494 , 2024

Link: https://doi.org/10.1016/..

2

Acute myocardial infarction preferentially alters low-abund..:

Ponnaiah, Maharajah ; Zakiev, Emile ; Lhomme, Marie...
Atherosclerosis Plus. 55 (2024) - p. 21-30 , 2024

Link: https://doi.org/10.1016/..

3

HDL functionality in type 1 and type 2 diabetes: new insigh..:

Chapman, M. John
Current Opinion in Endocrinology, Diabetes & Obesity. 29 (2022) 2 - p. 112-123 , 2022

Link: https://doi.org/10.1097/..

4

Concerns regarding NMR lipoprotein analyses performed on th..:

Krauss, Ronald M. ; Remaley, Alan T. ; John Chapman, M.
Journal of Clinical Lipidology. 16 (2022) 3 - p. 250-252 , 2022

Link: https://doi.org/10.1016/..

5

Cholesterol crystals and atherosclerotic plaque instability..:

John Chapman, M. ; Preston Mason, R.
Pharmacology & Therapeutics. 240 (2022) - p. 108237 , 2022

Link: https://doi.org/10.1016/..

6

Differentiating EPA from EPA/DHA in cardiovascular risk red..:

Toth, Peter P. ; Chapman, M. John ; Parhofer, Klaus G..
American Heart Journal Plus: Cardiology Research and Practice. 17 (2022) - p. 100148 , 2022

Link: https://doi.org/10.1016/..

7

Reducing residual cardiovascular risk in Europe: Therapeuti..:

Chapman, M. John ; Zamorano, Jose L. ; Parhofer, Klaus G.
Pharmacology & Therapeutics. 237 (2022) - p. 108172 , 2022

Link: https://doi.org/10.1016/..

8

Lipoprotein(a): Pathophysiology, measurement, indication an..:

Durlach, Vincent ; Bonnefont-Rousselot, Dominique ; Boccara, Franck...
Archives of Cardiovascular Diseases. 114 (2021) 12 - p. 828-847 , 2021

Link: https://doi.org/10.1016/..

9

Intensive low-density lipoprotein cholesterol lowering in c..:

Packard, Chris ; Chapman, M John ; Sibartie, Mahendra..
Heart. 107 (2021) 17 - p. 1369-1375 , 2021

Link: https://doi.org/10.1136/..

10

Triglyceride-rich lipoproteins and their remnants: metaboli..:

Ginsberg, Henry N ; Packard, Chris J ; Chapman, M John...
European Heart Journal. 42 (2021) 47 - p. 4791-4806 , 2021

Link: https://doi.org/10.1093/..

11

LDL Cholesterol: 'The Times They Are A-Changin':

Chapman, M John ; Giral, Philippe ; Therond, Patrice
Clinical Chemistry. 66 (2020) 9 - p. 1136-1139 , 2020

Link: https://doi.org/10.1093/..

12

Erratum to "2019 ESC/EAS guidelines for the management of d..:

Mach, Francois ; Baigent, Colin ; Catapano, Alberico L....
Atherosclerosis. 292 (2020) - p. 160-162 , 2020

Link: https://doi.org/10.1016/..

13

Quantifying atherogenic lipoproteins for lipid-lowering str..:

Nordestgaard, Børge G. ; Langlois, Michel R. ; Langsted, Anne...
Atherosclerosis. 294 (2020) - p. 46-61 , 2020

Link: https://doi.org/10.1016/..

14

Corrigendum to "2019 ESC/EAS Guidelines for the management ..:

Mach, Francois ; Baigent, Colin ; Catapano, Alberico L....
Atherosclerosis. 294 (2020) - p. 80-82 , 2020

Link: https://doi.org/10.1016/..

15

Efficacy and safety of icosapent ethyl in hypertriglycerida..:

Parhofer, Klaus G ; Chapman, M John ; Nordestgaard, Børge G
European Heart Journal Supplements. 22 (2020) Supplement_J - p. J21-J33 , 2020

Link: https://doi.org/10.1093/..